SJS Investment Consulting
SION icon

SJS Investment Consulting’s Sionna Therapeutics SION Stock Holding History

SJS Investment Consulting’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.19K Buy
416
+407
+4,522% +$9.35K ﹤0.01% 2173
2026
Q2 		$396 Buy
+9
New +$360 ﹤0.01% 2332

Other funds holding SION

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Chicago Partners Investment Group
Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

SJS Investment Consulting's SION Position: Q3 2026 in Review

SJS Investment Consulting increased its Sionna Therapeutics (SION) stake by 4,522% in Q3 2026, buying an estimated $9.35K and bringing the position to 416 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

SJS Investment Consulting first reported a position in SION in Q2 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • SJS Investment Consulting held 416 shares of Sionna Therapeutics worth $2.19K as of Q3 2026.
  • SJS Investment Consulting bought 407 Sionna Therapeutics shares in Q3 2026, an estimated $9.35K.
  • Sionna Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2173 holding.
  • SJS Investment Consulting first reported a position in Sionna Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.